We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
25 hedge funds and large institutions have $3.33M invested in CASI Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
30% more capital invested
Capital invested by funds: $2.55M → $3.33M (+$777K)
0.02% more ownership
Funds ownership: 0.37% → 0.39% (+0.02%)
11% less funds holding
Funds holding: 28 → 25 (-3)
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
Holders
25
Holders Change
-3
Holders Change %
-10.71%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
7
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$375K |
| 2 |
WSCM
Wellington Shields Capital Management
New York
|
+$272K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$37.1K |
| 4 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
+$20.5K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$18.7K |
